{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:22Z","timestamp":1791994582088,"version":"4.4.0"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune blistering diseases (AIBD) are paradigms of autoantibody-mediated organ-specific autoimmune disorders that involve skin and\/or mucous membranes. Compared to other autoimmune diseases, the pathogenicity of autoantibodies in AIBD is relatively well described. Pemphigus is a potentially lethal autoantibody driven autoimmune disorder with a strong HLA class II association. It is mainly characterized by IgG against the desmosomal adhesion molecules desmoglein 3 (Dsg3) and Dsg1. Several murine pemphigus models were developed subsequently, each allowing the analysis of a characteristic feature, such as pathogenic IgG or Dsg3-specific T or B cells. Thus, the models can be employed to preclinically evaluate potentially novel therapies. We here thoroughly summarize past and recent efforts in developing and utilizing pemphigus mouse models for pathomechanistic investigation and therapeutic interventions.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1169947","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T01:25:17Z","timestamp":1682558717000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Mouse models of pemphigus: valuable tools to investigate pathomechanisms and novel therapeutic interventions"],"prefix":"10.3389","volume":"14","author":[{"given":"Shirin","family":"Emtenani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hudemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2021.0136","article-title":"Bullous autoimmune dermatoses","volume":"118","author":"Beek","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90360-B","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.3390\/ijms21062178","article-title":"Paraneoplastic dermatoses: a brief general review and an extensive analysis of paraneoplastic pemphigus and paraneoplastic dermatomyositis","volume":"21","author":"Didona","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01259","article-title":"Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa","volume":"10","author":"Kim","year":"2019","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1525448113","article-title":"Multiplexed autoantigen microarrays identify HLA as a key driver of anti-desmoglein and -non-desmoglein reactivities in pemphigus","volume":"113","author":"Sajda","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13409","article-title":"Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical pemphigus","volume":"26","author":"Mindorf","year":"2017","journal-title":"Exp Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2011.04092.x","article-title":"The pathogenic role of autoantibodies in pemphigus vulgaris","volume":"36","author":"Pan","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.3390\/cells9122627","article-title":"Skin-associated b cells in the pathogenesis of cutaneous autoimmune diseases-implications for therapeutic approaches","volume":"9","author":"Fetter","year":"2020","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.291","article-title":"Persistence of anti-desmoglein 3 IgG(+) b-cell clones in pemphigus patients over years","volume":"135","author":"Hammers","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1046\/j.1523-1747.2000.00840.x","article-title":"Detection of antigen-specific b cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production","volume":"114","author":"Nishifuji","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03330350056029","article-title":"Transplacental transmission of pemphigus","volume":"249","author":"Wasserstrum","year":"1983","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/08820130902943097","article-title":"Involvement of T(H)1\/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-pemphigus vulgaris","volume":"38","author":"Satyam","year":"2009","journal-title":"Immunol Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.11.008","article-title":"Immunophenotyping in pemphigus reveals a T(H)17\/T(FH)17 cell-dominated immune response promoting desmoglein1\/3-specific autoantibody production","volume":"147","author":"Holstein","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.979277","article-title":"Detection of rare autoreactive T cell subsets in patients with pemphigus vulgaris","volume":"13","author":"Polakova","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148674","article-title":"Detection of autoreactive CD4+ T cells by MHC class II multimers in HLA-linked human autoimmune diseases","volume":"131","author":"Wieber","year":"2021","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1600-0625.2009.00948.x","article-title":"Animal models for autoimmune bullous dermatoses","volume":"19","author":"Bieber","year":"2010","journal-title":"Exp Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/019262301753178537","article-title":"Neonatal mouse model: review of methods and results","author":"McClain","year":"2001","journal-title":"Toxicol Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.299","article-title":"An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris","volume":"132","author":"Schulze","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH742>3.0.CO;2-W","article-title":"Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice","volume":"193","author":"Zillikens","year":"2001","journal-title":"J Pathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12525667","article-title":"A model for the study of autoimmune diseases applied to pemphigus: transplants of human oral mucosa to athymic nude mice binds pemphigus antibodies in vivo","volume":"76","author":"Buschard","year":"1981","journal-title":"J Invest Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.137.5.1091","article-title":"Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris","volume":"137","author":"Koch","year":"1997","journal-title":"J Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.0022-202x.2001.01643.x","article-title":"Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris","volume":"118","author":"Ohyama","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401081","article-title":"Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells","volume":"193","author":"Eming","year":"2014","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jid.2021.06.017","article-title":"Human desmocollin 3-Specific IgG antibodies are pathogenic in a humanized HLA class II transgenic mouse model of pemphigus","volume":"142","author":"Hudemann","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.884067","article-title":"Mechanisms causing acantholysis in pemphigus-lessons from human skin","volume":"13","author":"Egu","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.11.003","article-title":"Research techniques made simple: mouse models of autoimmune blistering diseases","volume":"137","author":"Pollmann","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12274679","article-title":"Experimentally induced pemphigus vulgaris in neonatal BALB\/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes","volume":"84","author":"Takahashi","year":"1985","journal-title":"J Invest Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J Clin Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12277362","article-title":"Brazilian Pemphigus foliaceus autoantibodies are pathogenic to BALB\/c mice by passive transfer","volume":"85","author":"Roscoe","year":"1985","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114426","article-title":"Monovalent fab\u2019 immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal balb\/c mice","volume":"85","author":"Rock","year":"1990","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(90)90045-R","article-title":"Pemphigus foliaceus antigen: characterization of an immunoreactive tryptic fragment from BALB\/c mouse epidermis recognized by all patients\u2019 sera and major autoantibody subclasses","volume":"57","author":"Labib","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1747.2003.12608.x","article-title":"Pathogenicity and epitope characteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies","volume":"121","author":"Hacker-Foegen","year":"2003","journal-title":"J Invest Dermatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.137.9.2835","article-title":"Defining the role of complement in experimental pemphigus vulgaris in mice","volume":"137","author":"Anhalt","year":"1986","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4408","article-title":"Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence","volume":"85","author":"Mascaro","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e50696","DOI":"10.1371\/journal.pone.0050696","article-title":"Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation","volume":"7","author":"Saito","year":"2012","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3390\/cells11101700","article-title":"Correction: zakrzewicz et\u00a0al. stabilization of keratinocyte monolayer integrity in the presence of anti-Desmoglein-3 antibodies through FcRn blockade with efgartigimod: novel treatment paradigm for pemphigus? cells 2022, 11, 942","volume":"11","author":"Zakrzewicz","year":"2022","journal-title":"Cells"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24185","article-title":"Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display","volume":"115","author":"Payne","year":"2005","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.4.2170","article-title":"Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3","volume":"170","author":"Tsunoda","year":"2003","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.172874","article-title":"p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris","volume":"286","author":"Mao","year":"2011","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700450","article-title":"Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation","volume":"126","author":"Kawasaki","year":"2006","journal-title":"J Invest Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701132","article-title":"Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies","volume":"128","author":"Ishii","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jid.2022.07.030","article-title":"IgG against the membrane-proximal portion of the desmoglein 3 ectodomain induces loss of keratinocyte adhesion, a hallmark in pemphigus vulgaris","volume":"143","author":"Hudemann","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.crimmu.2021.03.002","article-title":"Hybridoma technology: is it still useful","volume":"2","author":"Moraes","year":"2021","journal-title":"Curr Res Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01935","article-title":"Immunoadsorption of desmoglein-3-Specific IgG abolishes the blister-inducing capacity of pemphigus vulgaris IgG in neonatal mice","volume":"9","author":"Hofrichter","year":"2018","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1172\/JCI117349","article-title":"Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus","volume":"94","author":"Amagai","year":"1994","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10585.x","article-title":"Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine\/mycophenolate mofetil: a pilot study of 23 patients","volume":"166","author":"Kasperkiewicz","year":"2012","journal-title":"Br J Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2012.01075.x","article-title":"Immunoadsorption in dermatology","volume":"16","author":"Meyersburg","year":"2012","journal-title":"Ther Apher Dial"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14097","article-title":"S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid: 2019 update","volume":"18","author":"Schmidt","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"B52","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.ajpath.2011.04.015","article-title":"Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris","volume":"179","author":"Tsunoda","year":"2011","journal-title":"Am J Pathol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-017-8662-z","article-title":"Pemphigus: a comprehensive review on pathogenesis, clinical presentation and novel therapeutic approaches","volume":"54","author":"Pollmann","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5252","article-title":"Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris","volume":"103","author":"Mahoney","year":"1999","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007063430105","article-title":"Protection against pemphigus foliaceus by desmoglein 3 in neonates","volume":"343","author":"Wu","year":"2000","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/81385","article-title":"Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1","volume":"6","author":"Amagai","year":"2000","journal-title":"Nat Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01751.x","article-title":"Staphylococcal exfoliative toxin b specifically cleaves desmoglein 1","volume":"118","author":"Amagai","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.8.971","article-title":"The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus","volume":"134","author":"Vu","year":"1998","journal-title":"Arch Dermatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1523-1747.2002.01780.x","article-title":"Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion","volume":"119","author":"Hanakawa","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30784","article-title":"What protein kinases are crucial for acantholysis and blister formation in pemphigus vulgaris? a systematic review","volume":"237","author":"Brescacin","year":"2022","journal-title":"J Cell Physiol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.701809","article-title":"Autoantibody-specific signalling in pemphigus","volume":"8","author":"Schmitt","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501365200","article-title":"Desmosome signaling. inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization","volume":"280","author":"Berkowitz","year":"2005","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602973103","article-title":"p38MAPK inhibition prevents disease in pemphigus vulgaris mice","volume":"103","author":"Berkowitz","year":"2006","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.080391","article-title":"Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin","volume":"173","author":"Berkowitz","year":"2008","journal-title":"Am J Pathol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M808204200","article-title":"Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis","volume":"284","author":"Lee","year":"2009","journal-title":"J Biol Chem"},{"key":"B67","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/jid.2013.224","article-title":"MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris","volume":"134","author":"Mao","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60139","article-title":"Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering","volume":"123","author":"Spindler","year":"2013","journal-title":"J Clin Invest"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.04.040","article-title":"Pemphigus and pemphigoid: from disease mechanisms to druggable pathways","volume":"142","author":"Ellebrecht","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.438010","article-title":"A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis","volume":"288","author":"Bektas","year":"2013","journal-title":"J Biol Chem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12290","article-title":"EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship","volume":"23","author":"Sayar","year":"2014","journal-title":"Exp Dermatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18382","article-title":"The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient","volume":"182","author":"Ivars","year":"2020","journal-title":"Br J Dermatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2012.01441.x","article-title":"Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris","volume":"21","author":"Gil","year":"2012","journal-title":"Exp Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2009.00893.x","article-title":"An imbalance in Akt\/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris","volume":"18","author":"Pretel","year":"2009","journal-title":"Exp Dermatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00626","article-title":"Role of src and cortactin in pemphigus skin blistering","volume":"10","author":"Kugelmann","year":"2019","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702186200","article-title":"Evidence of key role of Cdk2 overexpression in pemphigus vulgaris","volume":"283","author":"Lanza","year":"2008","journal-title":"J Biol Chem"},{"key":"B77","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1365-2133.2008.08582.x","article-title":"The role of nitric oxide synthases in pemphigus vulgaris in a mouse model","volume":"159","author":"Marquina","year":"2008","journal-title":"Br J Dermatol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06147.x","article-title":"In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades","volume":"151","author":"Sanchez-Carpintero","year":"2004","journal-title":"Br J Dermatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.25.1_supplement.242.1","article-title":"The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting","volume":"179","author":"Spindler","year":"2011","journal-title":"Am J Pathol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002675","article-title":"Protective endogenous cyclic adenosine 5\u2019-monophosphate signaling triggered by pemphigus autoantibodies","volume":"185","author":"Spindler","year":"2010","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41467-022-35741-0","article-title":"Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus","volume":"14","author":"Sigmund","year":"2023","journal-title":"Nat Commun"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92253","article-title":"Stat3 regulates desmoglein 3 transcription in epithelial keratinocytes","volume":"2","author":"Mao","year":"2017","journal-title":"JCI Insight"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M309000200","article-title":"Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes","volume":"279","author":"Nguyen","year":"2004","journal-title":"J Biol Chem"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2009.00934.x","article-title":"Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis","volume":"18","author":"Grando","year":"2009","journal-title":"Exp Dermatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00161.2008","article-title":"Apoptosis is not required for acantholysis in pemphigus vulgaris","volume":"296","author":"Schmidt","year":"2009","journal-title":"m J Physiol Cell Physiol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.01.011","article-title":"Apoptosis in pemphigus","volume":"10","author":"Schmidt","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1023\/B:APPT.0000018795.05766.1f","article-title":"Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins","volume":"9","author":"Wang","year":"2004","journal-title":"Apoptosis"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1313.040","article-title":"The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients","volume":"1050","author":"Frusic-Zlotkin","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61239-4","article-title":"Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in pemphigus","volume":"167","author":"Arredondo","year":"2005","journal-title":"Am J Pathol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00370","article-title":"Soluble fas ligand is essential for blister formation in pemphigus","volume":"9","author":"Lotti","year":"2018","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.711","article-title":"Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2018.12.003","article-title":"Treatment update of autoimmune blistering diseases","volume":"37","author":"Kridin","year":"2019","journal-title":"Dermatol Clin"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24394","article-title":"Complete FcRn dependence for intravenous ig therapy in autoimmune skin blistering diseases","volume":"115","author":"Li","year":"2005","journal-title":"J Clin Invest"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02947.x","article-title":"Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris","volume":"142","author":"Mimouni","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04265.x","article-title":"Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris","volume":"162","author":"Mimouni","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2019.01.001","article-title":"Pharmacological advances in pemphigus","volume":"46","author":"Bilgic Temel","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20782","article-title":"Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal fc receptor inhibitor: a phase II multicentre, open-label feasibility trial","volume":"186","author":"Goebeler","year":"2022","journal-title":"Br J Dermatol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1016\/j.jid.2021.04.031","article-title":"Safety, tolerability, and activity of ALXN1830 targeting the neonatal fc receptor in chronic pemphigus","volume":"141","author":"Werth","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.54","article-title":"Mucosal pemphigus vulgaris anti-Dsg3 IgG is pathogenic to the oral mucosa of humanized Dsg3 mice","volume":"135","author":"Culton","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20327","article-title":"Modeling normal and pathological processes through skin tissue engineering","volume":"46","author":"Garcia","year":"2007","journal-title":"Mol Carcinog"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-002-0341-z","article-title":"Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris","volume":"294","author":"Shimizu","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57379","article-title":"Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice","volume":"121","author":"Takahashi","year":"2011","journal-title":"J Clin Invest"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2008.00776.x","article-title":"Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies","volume":"18","author":"Takae","year":"2009","journal-title":"Exp Dermatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16752","article-title":"Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)","volume":"34","author":"Joly","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06056.x","article-title":"A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice","volume":"151","author":"Aoki-Ota","year":"2004","journal-title":"Br J Dermatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2009.01033.x","article-title":"Confirmation of a disease model of pemphigus vulgaris: characterization and correlation between disease parameters in 90 mice","volume":"19","author":"Holm","year":"2010","journal-title":"Exp Dermatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jaci.2020.03.036","article-title":"Targeting inducible costimulator expressed on CXCR5(+)PD-1(+) T(H) cells suppresses the progression of pemphigus vulgaris","volume":"146","author":"Kim","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e0148919","DOI":"10.1371\/journal.pone.0148919","article-title":"Increased frequency of T follicular helper cells and elevated interleukin-27 plasma levels in patients with pemphigus","volume":"11","author":"Hennerici","year":"2016","journal-title":"PloS One"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e20190369","DOI":"10.1590\/1678-4685-gmb-2019-0369","article-title":"Beyond the HLA polymorphism: a complex pattern of genetic susceptibility to pemphigus","volume":"43","author":"Petzl-Erler","year":"2020","journal-title":"Genet Mol Biol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00226","article-title":"The genetics of pemphigus vulgaris","volume":"5","author":"Vodo","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00086.x","article-title":"Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals","volume":"110","author":"Hertl","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12919","article-title":"Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris","volume":"25","author":"Schmidt","year":"2016","journal-title":"Exp Dermatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.07.034","article-title":"Development of a mouse model of pemphigus vulgaris as a tool to evaluate nanoparticle induced antigen-specific tolerance","volume":"139","author":"Hudemann","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/exd.14263","article-title":"47th annual meeting of the arbeitsgemeinschaft dermatologische forschung (ADF): virtual, march 04-06, 2021","volume":"30","year":"2021","journal-title":"Exp Dermatol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e0259586","DOI":"10.1371\/journal.pone.0259586","article-title":"Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice","volume":"16","author":"Boch","year":"2021","journal-title":"PloS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1169947\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T01:25:21Z","timestamp":1682558721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1169947\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":115,"alternative-id":["10.3389\/fimmu.2023.1169947"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1169947","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"article-number":"1169947"}}